DXC Technology以患者为中心的综合护理解决方案为互操作性和患者参与创造新的机会
弗吉尼亚州泰森斯 (美国商业资讯)–DXC Technology (NYSE: DXC)今天推出先进的Patient-Centered Care(以患者为中心的护理)解决方案,这是一种可定制的个性化保健产品,其可为医疗保健提供者提供满足当今患者高期望的技术,而又不会牺牲成本控制和临床医生的满意度。...
View ArticleGenetron Health Contributes to China’s First Expert Consensus Statement on...
BEIJING The “Beijing Expert Consensus Statement on the Standardized Application of Next-Generation Sequencing Technology in Clinical Tests – Tumor (1st Edition)” has been officially published in...
View ArticleCGTN: Treatments show promise against COVID-19 in China
BEIJING A latest CGTN report shows that although there is no once-and-for-all treatment for COVID-19, Chinese medical professionals have discovered a couple of treatments by trial and error, which,...
View ArticleSmile Doctors和Dental Monitoring扩大并加快合作,在紧急状态期间向所有患者提供远程监测
巴黎 (美国商业资讯)– Smile Doctors是总部位于美国的最大的正畸DSO(牙科支持组织),在17个州设有220多家诊所,该公司已与Dental...
View Articleデノラがコロナウイルス(COVID-19パンデミック)との闘いでイタリアの市民保護機関を支援
ミラノ (ビジネスワイヤ) — インダストリエ・デノラ(Industrie De Nora)は、イタリア北部のミラノ近郊に4基の塩水電解システムを配備して市民保護局の活動を支援しています。塩水電解システムが作り出す次亜塩素酸ナトリウムは、塩素代替物として、硬質表面の消毒に適しており、世界保健機構(WHO)によれば、COVID-19ウイルスの拡散防止に効果があります。...
View ArticleCivil 20就COVID-19疫情向G20虚拟峰会做紧急声明:新的现实需要新的工作重点
沙特阿拉伯利雅得 (美国商业资讯)–Civil 20做出以下声明: 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20200323005536/zh-CN/ Inequalities risk (Photo: AETOSWire)...
View ArticleCOVID-19に関するG20バーチャル・サミットへのCivil 20からの緊急提言:新たな現実には新たな優先事項が必要
サウジアラビア・リヤド (ビジネスワイヤ) — 以下は、Civil 20(C20)からの提言です。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。:https://www.businesswire.com/news/home/20200324005270/ja/ Inequalities risk (Photo: AETOSWire)...
View ArticleIASO Biotherapeutics Raises $60 Million in Series B Financing Led by GL...
NANJING, China IASO Biotherapeutics (IASO BIO) today announced the completion of $60 million in series B financing led by GL Ventures, which is a venture capital fund of Hillhouse Capital focusing...
View Article三叶草与Dynavax合作评估新型冠状病毒候选疫苗与CpG 1018佐剂的联用
美国加州爱莫利维尔、中国成都 (美国商业资讯)–今天,三叶草生物制药有限公司(以下简称“三叶草生物”)宣布将与美国Dynavax Technologies Corporation公司(纳斯达克代码:DVAX)开展研发合作,推动其基于蛋白的新型冠状病毒候选疫苗“COVID-19 S-三聚体”的研究开发。Dynavax将为三叶草生物提供其专有的Toll样受体 9 (TLR9) 激动剂 的CpG...
View ArticleDynavax and Clover Biopharmaceuticals Announce Research Collaboration to...
EMERYVILLE, Calif. & CHENGDU, China Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and Clover...
View ArticleChina’s Mattress Maker SLEEMON Creatively Integrated the World’s Top...
MILAN Chinese mattress brand SLEEMON released the latest antibacterial mattress products recently. This series of mattresses integrates American DuPont Intellifresh technology and Swiss Sannitized...
View ArticleSleemon Held Launch Ceremony of New Series of Anti-Bacterial Mattress on...
TOKYO Recently, Chinese mattress brand SLEEMON, the biggest mattress supplier for IKEA and NITORI in the Asian-Pacific region, released the latest anti-bacteria mattress products. The new mattress...
View ArticleMasimo与大学医院联合发布旨在助力COVID-19响应的新型远程患者处治解决方案Masimo SafetyNet™
加州尔湾和克利夫兰 (美国商业资讯)–Masimo (NASDAQ: MASI)与俄亥俄州东北部最大的卫生系统大学医院(University Hospitals, UH)今天联合发布Masimo SafetyNet™,这是一款经济上可扩展的创新型患者管理系统,旨在帮助临床工作者远程治疗患者。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleNTHU’s Boron Neutron Capture Therapy Center Begins Treating Overseas Brain...
HSINCHU, Taiwan On February 14th the melodious strains of the fourth movement of Mahler’s Fifth Symphony were heard inside the building of Tsing Hua Open pool Reactor (THOR) at National Tsing Hua...
View ArticleSmileMate Virtual Consultationを5月31日まで無償提供
パリ (ビジネスワイヤ) — デンタル・モニタリングは先週、当社の遠隔歯科ソリューションの簡素化版となるSmileMate Virtual Consultation(スマイルメイト・バーチャル・コンサルテーション)を投入しました。これにより歯科専門家はHIPAAに準拠した方法で遠隔から新規患者の問診を行うことができます。...
View ArticleSmileMate虚拟看诊—— 5月31日前免费
巴黎 –(美国商业资讯)–Dental Monitoring上周宣布推出其远程牙科解决方案——简化版SmileMate虚拟看诊(SmileMate Virtual Consultation),使牙科专业人士能以符合《健康保险流通与责任法案》(HIPAA)要求的方式远程评估其新患者的问询。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleQurient Announces Publication in New England Journal of Medicine of Phase 2...
SEONGNAM-SI, Korea Qurient Co. Ltd. today announced the publication in the New England Journal of Medicine (NEJM) of positive results from the Phase 2 clinical trial for telacebec (Q203), a...
View ArticleNew Frontier Health Corporation Announces Fourth Quarter and Fiscal 2019...
BEIJING New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH”), today announced the unaudited...
View Article